• J&J’s Depuy Synthes Wins $16 Million in Patent Case
  • Elan Inviting Royalty Pharma Bid Shows Hostility Easing
  • J&J Says It Sells Final Stake in Elan for $332 Million
  • Merck to Cut Research Jobs as Perlmutter Sets Direction
  • Bankers-Turned-CEOs Fight for Elan in Year’s Top Hostile Bid
  • The Top Ten Stocks for Friday, June 14
  • Myriad, Hot Topic, Apple, Del’s: Intellectual Property
  • Elan Rises as Most Investors Reject Three Bid-Hald Plans
  • Sullivan & Cromwell, Haynes & Boone: Business of Law
  • Lilly Stops Trial of Experimental Alzheimer’s Drug
  • AbbVie Says It Can Be First With New Hepatitis C Drugs
  • Gene Patents Limited by Court in Mixed Ruling for Myriad
  • Pfizer’s Two New Top Pills Selling Slower Than Expected
  • European Stocks Little Changed as U.S. Data Beat Forecast
  • Flu Season Doctor Visits Reached Record at Early Peak
« Previous 1 2 3 4 5 Next »